BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9724481)

  • 1. Treatment of fulminant hepatic failure with intravenous prostaglandin E1.
    Sterling RK; Luketic VA; Sanyal AJ; Shiffman ML
    Liver Transpl Surg; 1998 Sep; 4(5):424-31. PubMed ID: 9724481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation.
    Henley KS; Lucey MR; Normolle DP; Merion RM; McLaren ID; Crider BA; Mackie DS; Shieck VL; Nostrant TT; Brown KA
    Hepatology; 1995 Feb; 21(2):366-72. PubMed ID: 7843707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.
    Abraham E; Baughman R; Fletcher E; Heard S; Lamberti J; Levy H; Nelson L; Rumbak M; Steingrub J; Taylor J; Park YC; Hynds JM; Freitag J
    Crit Care Med; 1999 Aug; 27(8):1478-85. PubMed ID: 10470753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine.
    Stanek B; Sturm B; Frey B; Hülsmann M; Bojic A; Berger R; Rödler S; Locker G; Grimm M; Laufer G; Pacher R
    J Heart Lung Transplant; 1999 Apr; 18(4):358-66. PubMed ID: 10226901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The optimal immunosuppressive protocol for the portal vein infusion of PGE1 and methylprednisolone in pediatric liver transplantation for fulminant hepatic failure of unknown etiology.
    Yamada Y; Hoshino K; Irie R; Tomita H; Kato M; Shimojima N; Fujino A; Hibi T; Shinoda M; Obara H; Itano O; Kawachi S; Tanabe M; Sakamoto M; Kitagawa Y; Kuroda T
    Pediatr Transplant; 2016 Aug; 20(5):640-6. PubMed ID: 27090203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E1 and survival in patients with the adult respiratory distress syndrome. A prospective trial.
    Holcroft JW; Vassar MJ; Weber CJ
    Ann Surg; 1986 Apr; 203(4):371-8. PubMed ID: 3516085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative prostaglandin e1 infusion in living donor liver transplantation: A double-blind, placebo-controlled randomized trial.
    Bharathan VK; Chandran B; Gopalakrishnan U; Varghese CT; Menon RN; Balakrishnan D; Sudheer OV; Dhar P; Surendran S
    Liver Transpl; 2016 Aug; 22(8):1067-74. PubMed ID: 27152759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group.
    Bone RC; Slotman G; Maunder R; Silverman H; Hyers TM; Kerstein MD; Ursprung JJ
    Chest; 1989 Jul; 96(1):114-9. PubMed ID: 2661155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative intravenous infusion of alprostadil (PGE1) does not improve renal function in hepatic transplant recipients.
    Manasia AR; Leibowitz AB; Miller CM; Silverstein JH; Schwartz M; Delgiudice R; Vallabhajosula S; Oropello JM; Benjamin E
    J Am Coll Surg; 1996 Apr; 182(4):347-52. PubMed ID: 8605558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of hepatic arterial infusion of prostaglandin E1 in the treatment of postoperative acute liver failure--report of a case.
    Sato T; Asanuma Y; Hashimoto M; Heianna J; Kusano T; Kurokawa T; Yasui O; Koyama K
    Hepatogastroenterology; 2000; 47(33):846-50. PubMed ID: 10919045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of prostaglandin E1 on non-pulmonary organ function during clinical acute respiratory failure. The Prostaglandin E1 Study Group.
    Slotman GJ; Kerstein MD; Bone RC; Silverman H; Maunder R; Hyers TM; Ursprung JJ
    J Trauma; 1992 Apr; 32(4):480-8; discussion 488-9. PubMed ID: 1569622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of treatment with prostaglandin E1 and N-acetylcysteine on pediatric liver transplant recipients: a single-center study.
    Bucuvalas JC; Ryckman FC; Krug S; Alonso MH; Balistreri WF; Kotagal U
    Pediatr Transplant; 2001 Aug; 5(4):274-8. PubMed ID: 11472606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma prostaglandin E1 concentrations and hemodynamics during intravenous infusions of prostaglandin E1 in humans and swine.
    Awas JA; Soteriou MC; Drougas JG; Stokes KA; Roberts LJ; Pinson CW
    Transplantation; 1996 Jun; 61(11):1624-9. PubMed ID: 8669108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prostaglandin E1 infusion in severe chronic heart failure.
    Pacher R; Stanek B; Hülsmann M; Sinzinger H
    Prostaglandins; 1997 Apr; 53(4):221-35. PubMed ID: 9167210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting.
    Zhao L; Lu J; Wang C; Zhao W; Qing E; Ma J
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1208-11. PubMed ID: 24090805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of contrast media-induced renal dysfunction with prostaglandin E1: a randomized, double-blind, placebo-controlled study.
    Sketch MH; Whelton A; Schollmayer E; Koch JA; Bernink PJ; Woltering F; Brinker J;
    Am J Ther; 2001; 8(3):155-62. PubMed ID: 11344383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of prostaglandin infusion in severe heart failure: preliminary clinical experience of repetitive administration.
    Serra W; Musiari L; Ardissino D; Gherli T; Montanari A
    Int J Cardiol; 2011 Jan; 146(1):e10-5. PubMed ID: 19176262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial.
    Klein AS; Cofer JB; Pruett TL; Thuluvath PJ; McGory R; Uber L; Stevenson WC; Baliga P; Burdick JF
    Gastroenterology; 1996 Sep; 111(3):710-5. PubMed ID: 8780576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication: results of a multicenter placebo-controlled double-blind trial.
    Diehm C; Balzer K; Bisler H; Bulling B; Camci M; Creutzig A; Gruss JD; Horsch S; Odemar F; Piehler U; Rogatti W; Scheffler P; Spengel F; Treese N; Turowski A; Waldhausen P; Weber B; Weiss T
    J Vasc Surg; 1997 Mar; 25(3):537-44. PubMed ID: 9081136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome.
    Mohrland JS; Porter JM; Smith EA; Belch J; Simms MH
    Ann Rheum Dis; 1985 Nov; 44(11):754-60. PubMed ID: 3904643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.